Analyst Recommendations

RBC Capital analyst issues OUTPERFORM recommendation for GMAB on July 15, 2024 04:35AM ET. GMAB was trading at $27.05 at issue of the analyst recommendation.The overall analyst consensus...

July 15, 2024   GMAB -0.62%

Morgan Stanley analyst issues EQUAL-WEIGHT recommendation for NVS on July 12, 2024 11:58AM ET. The previous analyst recommendation was Equal-Weight.NVS was trading at $111.855 at issue of the...

July 12, 2024   NVS -0.17%

Evercore ISI analyst issues OUTPERFORM recommendation for ARGX on July 12, 2024 08:03AM ET. The previous analyst recommendation was Outperform.ARGX was trading at $461.72 at issue of the...

July 12, 2024   ARGX 0.43%

Scotiabank analyst issues OUTPERFORM recommendation for BP on July 12, 2024 07:18AM ET. The previous analyst recommendation was Outperform.BP was trading at $35.05 at issue of the analyst...

July 12, 2024   BP 2.12%

Citigroup analyst issues BUY recommendation for WNS on July 12, 2024 06:13AM ET. The previous analyst recommendation was Buy.WNS was trading at $55.74 at issue of the analyst...

July 12, 2024   BP 2.12%

HSBC analyst issues HOLD recommendation for RYAAY on July 12, 2024 05:04AM ET. RYAAY was trading at $121.45 at issue of the analyst recommendation.The overall analyst consensus :...

July 12, 2024   RYAAY 1.03%

Goldman Sachs analyst issues SELL recommendation for DEO on July 11, 2024 06:28PM ET. DEO was trading at $131.59 at issue of the analyst recommendation.The overall analyst consensus...

July 11, 2024   DEO 4.06%

Goldman Sachs analyst issues SELL recommendation for ABEV on July 11, 2024 05:18PM ET. The previous analyst recommendation was Sell.ABEV was trading at $2.14 at issue of the...

July 11, 2024   ABEV 1.25%

Morgan Stanley analyst issues OVERWEIGHT recommendation for SAP on July 11, 2024 12:36PM ET. The previous analyst recommendation was Overweight.SAP was trading at $202.08 at issue of the...

July 11, 2024   SAP -0.76%

Guggenheim analyst issues BUY recommendation for GSK on July 11, 2024 06:43AM ET. The previous analyst recommendation was Buy.GSK was trading at $38.56 at issue of the analyst...

July 11, 2024   GSK -1.00%